Total Funding
77
64
Total FundingPre-Seed raised
Growth Score
38 pts
Heat Score
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
80382
Axent Biosciences is a biotech venture that engineers biomaterial technology for the development pipeline of stem cell therapy.
- David Schaffer: CSA, Director & Co-Founder,
- David Schaffer: Co-Founder and DirectorPast Role: Rewrite Therapeutics, Co-Founder and Consultant
About the Company
Axent Biosciences is a biotech venture that engineers biomaterial technology for the development pipeline of stem cell therapy. The company was co-founded by Riya Muckom and David Schaffer in 2019 and is headquartered in Oakland, California.
Women Founded
